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Abstract: Long term care facilities (LTCFs) are increasingly a place of care at end of life in Europe.
Longer residence in an LTCF prior to death has been associated with higher indicators of end of life
care; however, the relationship has not been fully explored. The purpose of this analysis is to explore
associations between length of stay and end of life care. The analysis used data collected in the
Palliative Care for Older People in care and nursing homes in Europe (PACE) study, a cross-sectional
mortality follow-back survey of LTCF residents who died within a retrospective 3-month period,
conducted in Belgium, England, Finland, Italy, the Netherlands and Poland. Primary outcomes were
quality of care in the last month of life, comfort in the last week of life, contact with health services in
the last month of life, presence of advance directives and consensus in care. Longer lengths of stay
were associated with higher scores of quality of care in the last month of life and comfort in the last
week of life. Longer stay residents were more likely to have advance directives in place and have a
lasting power of attorney for personal welfare. Further research is needed to explore the underlying
reasons for this trend, and how good quality end of life care can be provided to all LTCF residents.
Keywords: long-term care facility; care home; nursing home; length of stay; palliative care; end of
life care; epidemiology
1. Introduction
Long-term care facilities (LTCFs) are becoming a common place of death for older adults [1–3],
especially those with dementia [4,5]. Although terminology and typology varies between countries,
a LTCF, including care homes and nursing homes, generally refers to a collective institutional setting
where care is provided to older adults, who live there, 24 h a day, seven days a week [6].
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Ensuring LTCF residents approaching end of life receive appropriate care is challenging; residents
may be frail, with multiple, complex care needs, and may be unable to either establish or communicate
their preferences at end of life. Long term care facilities are often staffed by a combination of registered,
qualified nurses and care assistants, who may have limited knowledge of end of life care for older adults
and limited access to specialist services to support end of life care [7]. In addition, LTCF managers
and their staff may lack clarity in defining and identifying end of life, or their role or responsibility
in providing subsequent care within the facility [8]. In many European countries, end of life care in
LTCFs in not well supported at a national level; in a review of 29 countries only eight had national
policies which specifically addressed end of life care in LTCFs [9].
Palliative care is defined as “an approach that improves the quality of life of patients and their
families facing the problem associated with life-threatening illness, through the prevention and relief
of suffering by means of early identification and impeccable assessment and treatment of pain and
other problems, physical, psychosocial and spiritual” [10]. The term “end of life care” is often used
synonymously with palliative care in the UK, and refers to “an extended period of 1 to 2 years during
which the patient/family and health professionals become aware of the life-limiting nature of their
illness” [11]. Previous studies have found that the adoption of a palliative care approach in LTCFs
led to a reduction in deaths outside the LTCF [12], an increase in the numbers of completed advance
directives [13], improvements in end-of-life communication between residents, relatives and health
professionals [14–16] and improvements in staff knowledge [17–19].
Numerous interventions have been developed to improve the provision and quality of end
of life care in LTCFs, including staff education [20,21], inter-professional collaborations and care
coordination [22,23], either through individual initiatives or as part of multicomponent interventions,
such as the Liverpool Care Pathway [24], Gold Standards Framework for Care Homes [25] or the
Steps to Success intervention [26]. The time point at which these initiatives aim to change the care
provided to a resident varies; whereas the Liverpool Care Pathways focuses on care in the last days of
life [24], interventions focusing on communicating preferences at end of life may be introduced either
at admission or four to six weeks post admission. For residents who die shortly after admission, such
activities may occur simultaneously.
Although specific guidelines exist for providing end of life care specifically to older adults [27]
and those with dementia [28], less research has explored variation in the palliative care delivered to
specific subgroups, such as women or older adults with little support from family carers. In particular,
it is unclear whether the end of life care received by residents admitted shortly before death differs
from the care for those who have lived in a facility for many months or even years [29]. Previous
studies exploring care at end of life have found that residents with longer length of stay before death
had fewer hospitalisations, were more likely to be receive palliative drug therapy, less likely to be
undertreated for non-pain symptoms and more likely to have documented do-not-resuscitate (DNR)
orders in place [30–33].
At present, no published research has specifically explored the association between length of stay
in a LTCF and the experience of residents at end of life, collected either directly from the resident or
by proxy measures. None of the research previously discussed included length of stay as a primary
explanatory variable of the end of life care indicators investigated, and none report conducting
any prior analysis to explore factors associated with length of stay in the data. Therefore, previous
research findings may not control for all characteristics associated with longer lengths of stay, leading
to associations between end of life care and resident characteristics, such as age, gender, dementia
diagnosis or marital status, being confused with associations with length of stay. In addition, it is
common for LTCF residents to fall into one of two broad populations, those with relatively short stays
before death and those who have resided in the facility for many years [8]. In previous analysis of
length of stay and end of life care in LTCFs, residents with different lengths of stay have commonly
been separated into residents residing in the facility either 6 months, 1 year or 2 years before death,
leaving the experience of residents with longer lengths of stay unexplored.
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A greater understanding of how the experience of residents at end of life varies is a research
priority, and can inform the development of interventions aiming to improve the provision and quality
of end of life care in LTCFs, and explore variation within a heterogeneous population. In this analysis
we used data from the Palliative Care for Older People in care and nursing homes in Europe (PACE)
cross-sectional study, which aimed to compare quality of dying and end of life care in deceased
residents of LTCFs in six European countries [34]. The purpose of this analysis is to explore whether
length of stay in LTCF residents is related to five indicators of end of life care; quality of care in the
last month of life, comfort in the last week of life, contact with health services in the last month of
life, presence of advance directives and consensus among those involved in care and treatment, using
staff-reported data on deceased residents from LTCFs in six European countries.
2. Materials and Methods
2.1. Study Design and Setting
The data used in this analysis are from a cross-sectional, mortality follow back survey of deceased
residents; the PACE study [35]. The PACE study was conducted in a sample created, where possible,
using national lists of LTCFs in Belgium, England, Finland, Italy, the Netherlands and Poland, recruited
using a proportionally stratified random sampling framework [36].
In LTCFs that consented to take part in the study, data were collected on residents who had died
in a 3-month retrospective period during 2015. Residents were included in the study if they had died
in the facility or after transfer to hospital. For each identified resident, demographic information was
collected from either administrative staff or the facility manager (response rate 95.7%), and a postal
questionnaire sent to a LTCF staff member regarded as most involved in the resident’s care (81.6%).
A full description of the study methodology, including ethical approvals, are described elsewhere [35].
2.2. Measurements
A LTCF staff member (nurse or care assistant), identified by a key person appointed by the LTCF
manager as most involved in the residents’ care, self-reported the main outcomes used in this analysis.
Data were collected on (i) quality of care in the last month of life, (ii) comfort in the last week of life,
(iii) contact with health services in the last month, (iv) presence of advance directives, and (v) consensus
among those involved in care and treatment.
Quality of care in the last month of life (i) was measured using the Quality of Dying in Long-Term
Care (QoD-LTC) scale [37]. The questionnaire has 11 items, with higher scores indicating better quality
of care. Three subscales, personhood, closure and preparatory tasks, can be generated. Comfort in
the last week of life (ii) was measured using the End-of-Life in Dementia Scale Comfort Assessment
While Dying (EOLD-CAD) scale [38]. The questionnaire has 14 items, with higher scores indicating
higher levels of comfort. Four subscales, physical distress, dying symptoms, emotional distress and
wellbeing, can be calculated.
The data on contact with health services at end of life (iii) were number of visits either received or
made by a physician during the last month of life, number of admissions to a hospital, geriatric ward,
intensive care unit or general ward (for more than 24 h) during the last month of life, and the number
of visits to a hospital emergency room (for less than 24 h) during the last month of life. Resident’s
place of death was categorised as either death in a LTCF or in a hospital.
The presence of advance directives (iv) was determined using four outcomes. Firstly, whether
the resident had any written advance directives in place, including a do not resuscitate in case of a
cardiac or respiratory arrest order, do not transfer to a hospital order, a request to discontinue the use
of, or do not use, other treatments, or a request to try all life sustaining measures. Secondly, whether
the resident had a lasting power of attorney for personal welfare. Thirdly, whether a staff member ever
spoke with the resident about medical treatments he or she would or would not want in the last phase
of life or about the preferred course of care in the last phase of life. The final outcome was whether a
Int. J. Environ. Res. Public Health 2020, 17, 2742 4 of 14
staff member spoke with a relative of the resident about medical treatments he or she would or would
not want in the last phase of life or about the preferred course of care in the last phase of life, prior to a
decision being made.
The degree to which those involved in care were in agreement (consensus) on care and treatment
in the last month of the resident’s life (v), from the perspective of staff members, was measured among
LTCF staff, among representatives/family and among all those involved in the resident’s care. Staff
members were asked to select one of three choices for each question; full consensus, consensus on major
issues or no consensus. In this analysis, the answers were categorised as consensus (full consensus or
consensus on major issues) or no consensus (no consensus).
Length of stay was calculated in days using date of admission to the LTCF and date of death.
Residents were grouped based on their lengths of stay in seven groups: under 1 month, 1 to 3 months,
3 months to 1 year, 1 to 2 years, 2 to 3 years, 3 to 5 years and over 5 years. The groups were demarcated
to ensure relatively similar sample sizes in each group, and to allow analysis of longer stay residents.
Ten variables previously identified as associated with length of stay in the dataset were included in the
analysis to control for resident, LTCF and country characteristics [39]. These were age, gender, marital
status, place of admission, presence of cancer, presence and severity of dementia, physical functioning,
LTCF type, LTCF funding status and country.
Age and gender were determined at the time of admission. Severity of dementia was calculated
using a combined score from the Global Dementia Scale (GDS) [40] and the Cognitive Performance
Scale (CPS) [41]. The Bedford Alzheimer Nursing-Severity Scale (BANS-S) [42] was used to measure
physical functioning.
Each LTCF was categorised by the type of care offered, as type 1, 2 or 3 [9]. Type 1 facilities offer
on-site care provided by physicians, nurses and care assistants (available in Italy, the Netherlands,
and Poland). Type 2 facilities offer on-site care provided by nurses and care assistants with medical
provision provided by local, external primary care services (available in all countries). Type 3 facilities
offer on-site care provided by care assistants, with nursing and medical provision provided by local,
external primary care services (available in England). Funding status of the LTCF was classed as either
public (non-profit), private (non-profit) or private (for profit).
2.3. Statistical Analysis
Data were collected on 1707 deceased residents from 322 LTCFs. Residents were excluded from
the sample if length of stay was less than one day or could not be calculated, if a resident was missing
data on age or was younger than 65 years of age on admission, or no questionnaire was returned
by LTCF staff (n = 470), resulting in a final sample of 1237 residents. Non-response analysis was
conducted on residents for whom staff returned questionnaires and for those whom staff did not return
questionnaires, based on the length of stay. Sample characteristics and frequencies for each of the
outcomes are reported by length of stay.
For continuous outcomes, associations between length of stay and quality of care in the last month
of life (QoD-LTC), comfort in the last week of life (EOLD-CAD) and their subscales were determined
using generalised linear regression models. In each model, total scores of the QoD-LTC, EOLD-CAD
and their subscales were added as the dependent variable, with length of stay added as a covariate.
Resident, facility and country level characteristics previously identified as varying by length of stay
were also added to each model as covariates; these were age, gender, marital status, place of admission,
cancer, dementia, physical functioning, LTCF type, LTCF funding status and country. A variable
identifying each LTCF was added as a random factor. Goodness of fit for each model was assessed
using the Akaike information criterion.
For binary outcomes, associations between length of stay and the presence of advance directives,
contact with health services and consensus on care and treatment were determined using logistic
regression models. In each model, the outcome was added as a dependent variable, with length of
stay added as a covariate along with resident, facility and country level characteristics. A variable
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identifying each LTCF was added as a random factor. The adequacy of the model was assessed using
the Hosmer and Lemeshow’s goodness-of-fit test. Interactions between age and gender were tested
and added to the model where appropriate. Multi-collinearity was checked using variance inflation
factors [43].
A positive coefficient indicates that an increase in the value of the dependant variable is associated
with an increase in the value of the independent variable. A negative coefficient indicates that a
decrease in the value of the dependant variable is associated with a decrease in the value of the
independent variable. Statistical significance was set as p < 0.05. All analyses were performed using
Stata (version 16) [44].
3. Results
The final sample included 1237 residents; 262 in Belgium, 252 in Finland, 192 in Italy, 193 in the
Netherlands, 263 in Poland and 75 in England. No significant differences were identified in the lengths
of stay of residents for whom a staff questionnaire was or was not completed and returned (p = 0.356).
The median length of stay was 73.4 weeks (range 16–103.9 weeks) and average length of stay was
126 weeks (SD 157), ranging from 93 (SD 156) to 163 (SD 182) weeks. The mean age of residents at
admission was 83.9 years (SD 7.2), ranging from 81.56 (SD 7.12) in residents with length of stay over
5 years to 85.45 (SD 7.2) in residents with a length of stay of 3 months to 1 year. The percentage of
residents who were female was 67.6%, ranging from 55.8% in residents with length of stay of 1 to
3 months and 81.1% in residents with length of stay over 5 years. Characteristics of the sample and
main outcomes are shown in Tables 1 and 2.
3.1. Quality of End of Life Care in the Last Month of Life (QoD-LTC)
Associations between end of life care and length of stay are shown in Table 3. Length of stay was
associated with quality of care in the last month of life in the multivariate model. Total scores on the
QoD-LTC were significantly higher in residents with a length of stay of 3 months to 1 year compared to
under 1 month (p = 0.002); and increase significantly up to and over 5 years (p < 0.001). Scores on the
personhood subscale were significantly higher in residents with a length of stay of 3 months to 1 year
compared to under 1 month (p = 0.010); and increase significantly up to and over 5 years (p = 0.001).
Scores on the closure subscale were also significantly higher in residents with a length of stay of 1 to
3 months compared to under 1 month (p = 0.014); and increase significantly up to and over 5 years
(p < 0.001). Scores on the preparatory tasks subscale were significantly higher between 1 to 2 years
(p = 0.027), 2 to 3 years (p = 0.002) and 3 to 5 years (p < 0.001), and approached statistical significance at
over 5 years (p = 0.052).
3.2. Comfort in the Last Week of Life (EOLD-CAD)
Total scores on the EOLD-CAD were higher in residents with longer lengths of stay, however
length of stay was significantly associated with comfort in the last week of life at only over 5 years
compared to under 1 month (p = 0.005) in the multivariate model. Scores on the physical distress
subscale were significantly higher in residents with a length of stay between 1 to 2 years (p = 0.040),
3 to 5 years (p = 0.027) and over 5 years (p < 0.001). Scores on the emotional distress subscale were
significantly higher in residents with a length of stay of 3 to 5 years (p = 0.007) and over 5 years
(p = 0.001) and on the wellbeing subscale at over 5 years (p = 0.001). Scores on the dying symptoms
subscale were not significantly associated with length of stay.
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5 years 5 years + Total p value
n = 163 n = 135 n = 223 n = 208 n = 162 n = 160 n = 186 n = 1237
Age at admission—mean (SD) 83.8 (8.1) 83.7 (7.7) 85.5 (7.2) 84.56 (6.7) 84 (7.1) 83.67 (6) 81.6 (7.2) 83.9 (7.2) <0.001
Gender—female (%) 91 (55.8) 87 (64.4) 142 (64.3) 132 (64.4) 110 (68.8) 119 (74.4) 150 (81.1) 831 (67.6) <0.001
Marital status—married or in a civil partnership 47 (34.8) 37 (31.6) 47 (22.7) 47 (24.1) 35 (22.3) 27 (17.4) 13 (7.2) 253 (22.1) <0.001
Place of admission (%)
Community 54 (34.6) 49 (39.8) 87 (43.9) 82 (45.1) 68 (47.9) 80 (58.4) 112 (69.6) 532 (48.4) <0.001
Hospital 78 (50) 52 (42.2) 75 (37.9) 59 (32.4) 39 (27.5) 30 (21.9) 32 (19.9) 365 (33.2) <0.001
Other LTCF 24 (15.4) 22 (17.9) 36 (18.2) 41 (22.5) 35 (24.7) 27 (19.7) 17 (10.6) 202 (18.4) 0.036
BANS-S—total score—mean (SD) * 20.51 (5.4) 20.00 (4.9) 19.47 (4.8) 19.39 (4.7) 19.46 (4.5) 20.15 (4.3) 19.68 (4.9) 19.77 (4.8) 0.239
Cancer (%) 26 (16) 29 (21.5) 39 (17.5) 31 (14.9) 21 (13) 17 (10.6) 18 (9.7) 181 (14.6) 0.046
Dementia (%)
Resident did not have dementia 63 (48.5) 39 (34.2) 56 (29) 57 (31.5) 33 (23.1) 38 (27.9) 52 (31.9) 338 (31.9) 0.001
Mild or moderate 11 (8.5) 24 (21.1) 31 (16.1) 25 (13.8) 17 (11.9) 11 (8.09) 15 (9.2) 134 (12.6) 0.014
Severe, very severe or advanced dementia 56 (43.1) 51 (44.8) 106 (54.9) 99 (54.7) 93 (65.1) 87 (64) 96 (58.9) 588 (55.5) 0.001
LTCF type (%)
Type 1—onsite nursing/onsite physician 79 (48.8) 53 (39.6) 60 (27.7) 39 (19.2) 36 (22.4) 22 (13.9) 27 (14.6) 316 (25.9) <0.001
Type 2—onsite nursing/offsite physician 81 (50) 79 (59) 153 (70.5) 158 (77.5) 123 (76.4) 129 (81.7) 146 (78.9) 869 (71.2) <0.001
Type 3—offsite nursing/offsite physician 2 (1.2) 2 (1.5) 4 (1.8) 7 (3.4) 2 (1.2) 7 (4.4) 12 (6.5) 36 (3) 0.023
LTCF ownership (%)
Public—non profit 91 (56.2) 88 (65.7) 129 (60) 120 (59.1) 95 (59.8) 101 (63.9) 121 (65.4) 745 (61.3) 0.497
Private—non profit 45 (27.8) 26 (19.4) 53 (24.7) 46 (22.7) 44 (27.7) 32 (20.3) 40 (21.6) 286 (23.5) 0.427
Private—profit 26 (16.1) 20 (14.9) 33 (15.4) 37 (18.2) 20 (12.6) 25 (15.8) 24 (13) 185 (15.2) 0.790
Country (%)
Belgium 17 (10.4) 19 (14.1) 49 (22) 46 (22.1) 40 (24.7) 35 (21.9) 56 (30.1) 262 (21.2) <0.001
Finland 25 (15.3) 27 (20) 41 (18.4) 53 (25.5) 35 (21.6) 43 (26.9) 28 (15.1) 252 (20.4) 0.029
Italy 29 (17.8) 19 (14.1) 39 (17.5) 37 (17.8) 26 (16.1) 25 (15.6) 17 (9.1) 192 (15.5) 0.228
Netherlands 14 (8.6) 16 (11.9) 34 (15.3) 35 (16.8) 30 (18.5) 25 (15.6) 39 (21) 193 (15.6) 0.045
Poland 71 (43.6) 47 (34.8) 47 (21.1) 25 (12) 22 (13.6) 20 (12.5) 31 (17) 263 (6.1) <0.001
England 7 (4.3) 7 (5.2) 13 (5.8) 12 (5.8) 9 (5.6) 12 (7.5) 15 (8.1) 75 (6.1) 0.797
BANS-S: Bedford Alzheimer Nursing Severity Scale; LTCF: long term care facility; SD: standard deviation. * higher scores indicate poorer physical functioning. p values calculated using
Pearson chi-square and one way ANOVAs. A p value of <0.05 indicated a statistically significant difference in values between lengths of stay. Missing data: gender n = 8, marital status
n = 90, place of admission n = 138, BANS-S n = 22, dementia n = 177, LTCF type n = 16 and LTCF ownership n = 21.
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to 5 years 5 years + Total p value
n = 163 n = 135 n = 223 n = 208 n = 162 n = 160 n = 186 n = 1237
Quality of care in the last month of life (QoD-LTC)
Total score—mean (SD) 35.80 (6.96) 37.75 (6.97) 38.59 (7.56) 38.89 (7.73) 39.55 (7.32) 40.06 (8.08) 40.41 (7.65) 38.79 (7.62) <0.001
Personhood subscale—mean (SD) 19.67 (3.35) 20.19 (3.52) 20.54 (3.55) 20.99 (2.94) 21.17 (3.56) 21.11 (3.61) 21.09 (3.39) 20.70 (3.44) <0.001
Closure subscale—mean (SD) 8.01 (2.72) 9.03 (2.77) 9.21 (2.91) 9.29 (2.84) 9.14 (2.94) 9.47 (2.96) 9.72 (9.72) 9.15 (9.15) <0.001
Preparatory tasks subscale—mean (SD) 6.92 (3.41) 7.70 (3.26) 8.02 (3.80) 8.07 (3.95) 8.32 (3.76) 8.47 (4.08) 8.58 (3.74) 8.03 (3.77) 0.001
Comfort in the last week of life (EOLD-CAD)
Total score—mean (SD) 29.63 (5.50) 29.46 (5.78) 30.58 (5.33) 31.07 (5.07) 30.41 (5.42) 31.20 (5.21) 31.82 (5.06) 30.67 (5.36) 0.001
Physical distress subscale—mean (SD) 4.29 (1.70) 4.35 (1.80) 4.77 (1.77) 4.85 (1.66) 4.75 (1.64) 4.76 (1.81) 5.16 (1.57) 4.73 (1.72) <0.001
Dying symptoms subscale—mean (SD) 6.86 (2.47) 6.97 (2.24) 7.07 (2.12) 7.15 (1.99) 7.04 (2.04) 7.05 (2.13) 7.17 (2.22) 7.05 (2.17) 0.874
Emotional distress subscale—mean (SD) 8.90 (2.69) 9.01 (2.47) 9.36 (2.27) 9.54 (2.17) 9.55 (2.08) 9.69 (2.13) 9.88 (1.85) 9.44 (2.25) 0.001
Wellbeing subscale—mean (SD) 5.02 (1.90) 5.23 (1.71) 5.64 (1.81) 5.83 (1.91) 5.68 (1.86) 5.82 (1.91) 6.09 (1.78) 5.65 (1.87) 0.001
Contact with health services in the last month of life
Physician visits (%)
0–5 visits 56 (51.38) 53 (54.64) 94 (58.75) 101 (70.63) 65 (61.90) 68 (55.74) 78 (60.47) 515 (59.54) 0.055
More than five visits 53 (48.62) 44 (45.36) 66 (41.25) 42 (29.37) 40 (38.10) 54 (44.26) 51 (39.53) 350 (40.46)
Hospital admissions (%)
None 98 (70.50) 98 (79.03) 164 (77.36) 159 (80.71) 125 (81.70) 126 (82.35) 157 (86.26) 927 (79.91) 0.028
One or more visits 41 (29.50) 26 (20.97) 48 (22.64) 38 (19.29) 28 (18.30) 27 (17.65) 25 (13.74) 233 (87.14)
Emergency department visits (%)
None 124 (88.57) 107 (86.29) 185 (86.85) 160 (82.47) 138 (90.20) 135 (87.10) 161 (89.44) 1010 (87.14) 0.396
One or more visits 16 (11.43) 17 (13.71) 28 (13.15) 34 (17.53) 15 (9.80) 20 (12.90) 19 (10.56) 149 (12.86)
Place of death (%)
LTCF 133 (84.7) 106 (82.8) 195 (88.6) 173 (84.8) 139 (86.9) 145 (90.6) 159 (84) 1050 (86.5) 0.460
Hospital 24 (15.3) 22 (17.2) 25 (11.4) 31 (15.2) 21 (13.1) 15 (9.4) 26 (14.1) 164 (13.5)
Presence of advance directives
Resident had any written advance directives in place (%) 33 (20.3) 46 (34.07) 81 (36.3) 81 (38.9) 60 (37) 74 (46.3) 88 (47.3) 463 (37.4) <0.001
Resident had lasting power of attorney for personal welfare (%) 38 (28.2) 39 (36.5) 57 (32.4) 63 (37.8) 44 (35.8) 42 (32.1) 62 (43.4) 345 (35.1) 0.182
Staff spoke with the resident about end of life care (%) 20 (13.5) 28 (22.3) 50 (23.4) 51 (24.7) 39 (24.7) 39 (25.2) 60 (33.6) 287 (24.7) 0.005
Staff spoke with the relative about end of life care (%) 70 (44.9) 55 (43) 129 (60.6) 128 (61.9) 105 (66.9) 112 (71.4) 110 (60.8) 709 (59.2) <0.001
Consensus in care and treatment
Among staff (%) 152 (97.4) 125 (99.2) 203 (98.1) 193 (97.5) 152 (99.4) 146 (97.3) 172 (98.9) 1143 (98.2) 0.673
Among family (%) * 142 (98.6) 108 (97.3) 187 (96.9) 183 (97.7) 147 (99.3) 137 (97.2) 158 (100) 1062 (98.2) 0.299
Among all involved (%) 152 (98.7) 120 (97.6) 200 (98.1) 194 (97.5) 152 (99.4) 146 (98) 173 (98.9) 1137 (98.3) 0.836
QoD-LTC: Quality of Dying in Long-Term Care. EOLD-CAD: End of Life in Dementia Scale-Comfort Assessment while Dying. Theoretical range of QoD-LTC—total score: 11–55,
personhood subscale: 5–25, closure subscale: 3–15, preparatory tasks: 3–15. Theoretical range of EOLD-CAD—total score: 14–42, physical distress subscale: 4–12, dying symptoms
subscale: 4–12, dying symptoms subscale: 4–12, emotional distress: 4–12, wellbeing subscale: 3–9. Theoretical ranges based on no missing data. LTCF: long term care facility; SD: standard
deviation. p values calculated using Pearson chi-square and one way ANOVAs. A p value of <0.05 indicated a statistically significant difference in values between lengths of stay. Missing
data: QoD-LTC total score n = 41, personhood subscale n = 13, closure subscale n = 18, preparatory tasks subscale n = 32, EOLD-CAD total score n = 76, physical distress n = 43, dying
symptoms n = 42, emotional distress n = 50, wellbeing subscale n = 61, physician visits n = 372, hospital admissions n = 77, emergency department visits n = 78, place of death n = 23,
lasting power of attorney n = 255, staff member spoke with the resident about end of life care n = 49, staff member spoke with the relative about end of life care n = 38, consensus of care
among staff n = 73, consensus of care among family n = 89, consensus of care among all involved n = 80. * family were not involved in residents care n = 66.
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Table 3. Associations between indicators of end of life care of deceased LTCF and length of stay in a LTCF until death.












to 5 years 5 years +
Quality of care in the last month of life (QoD-LTC)
Total score ref 1.14 (–0.77–3.05) 2.71 (1.00–4.42) ** 3.03 (1.23–4.84) ** 4.03 (2.15–5.90) ** 4.80 (2.87–6.72) ** 4.16 (2.21–6.11) **
Personhood subscale ref 0.48 (–0.39–1.36) 1.02 (0.24–1.80) * 1.34 (0.53–2.15)** 1.31 (0.47–2.15) ** 1.53 (0.68–2.38) ** 1.41 (0.56–2.26) **
Closure subscale ref 0.91 (0.18–1.64) 1.21 (0.56–1.86) * 1.32 (0.65–1.99) ** 1.26 (0.57–1.96) ** 1.64 (0.94–2.34) ** 1.72 (1.02–2.41) **
Preparatory tasks subscale ref 0.20 (–0.73–1.14) 0.72 (–0.12–1.56) 1.00 (0.11–1.88) * 1.45 (0.53–2.37) ** 1.69 (0.75–2.63) ** 0.94 (–0.01–1.90)
Comfort in the last week of life (EOLD-CAD)
Total score ref –0.36 (–1.75–1.04) 0.15 (–1.11–1.40) 0.66 (–0.62–1.93) 0.31 (–1.02–1.64) 1.14 (–0.21–2.49) 1.88 (0.58–3.18) **
Physical distress subscale ref 0.16 (–0.25–0.58) 0.35 (–0.03–0.73) 0.41 (0.02–0.79) * 0.34 (–0.06–0.75) 0.46 (0.05–0.87) * 0.86 (0.46–1.25) **
Dying symptoms subscale ref 0.05 (–0.48–0.59) –0.10 (–0.58–0.38) –0.15 (–0.63–0.33) –0.07 (–0.58–0.44) –0.01 (–0.53–0.50) 0.06 (–0.44–0.55)
Emotional distress subscale ref 0.10 (–0.46–0.65) 0.31 (–0.19–0.81) 0.34 (–0.16–0.85) 0.49 (–0.05–1.02) 0.74 (0.20–1.28) ** 0.88 (0.36–1.39) **
Wellbeing subscale ref 0.03 (–0.42–0.48) 0.26 (–0.14–0.66) 0.40 (–0.01–0.82) 0.29 (–0.14–0.72) 0.41 (–0.02–0.85) 0.73 (0.31–1.15) **
Contact with health services in the last month of life
Physician visits (0–5 visits vs. more than five visits) ref 0.15 (–0.49–0.80) 0.02 (–0.57–0.62) –0.47 (–1.12–0.18) –0.09 (–0.76–0.58) 0.13 (–0.50–0.77) –0.29 (–0.92–0.35)
Hospital visits (none vs. one or more visits) ref –0.58 (–1.33–0.16) –0.31 (–0.96–0.34) –0.53 (–1.22–0.17) –0.51 (–1.23–0.21) –0.67 (–1.40–0.07) –1.01 (–1.76–0.26) **
Emergency department admissions (none vs. one or more visits) ref 0.34 (–0.50–1.17) 0.11 (–0.66–0.88) 0.30 (–0.46–1.06) –0.04 (–0.88–0.81) 0.07 (–0.76–0.90) –0.12 (–0.94–0.71)
Place of death (LTCF vs. hospital) ref 0.30 (–0.57–1.17) –0.50 (–1.33–0.33) –0.29 (–1.13–0.55) –0.15 (–1.03–0.73) –1.03 (–2.04–0.03)* –0.72 (–1.66–0.22)
Presence of advance directives
Resident had any written advance directives in place ref 0.58 (–0.17–1.33) 0.60 (–0.09–1.29) 0.67 (–0.02–1.37) 0.58 (–0.14–1.30) 1.21 (0.46–1.96) ** 0.91 (0.18–1.64) *
Resident had lasting power of attorney for personal welfare ref 0.60 (–0.01–1.21) 0.53 (–0.04–1.10) 0.87 (0.28–1.46) ** 0.72 (0.09–1.36) * 0.73 (0.10–1.36) * 1.10 (0.48–1.73) **
Staff spoke with the resident about end of life care ref 0.66 (–0.14–1.45) 0.49 (–0.25–1.23) 0.64 (–0.11–1.38) 0.54 (–0.23–1.31) 0.65 (–0.15–1.45) 0.86 (0.08–1.64) *
Staff spoke with the relative about end of life care ref –0.46 (–1.07–0.16) 0.25 (–0.30–0.81) 0.14 (–0.43–0.71) 0.51 (–0.10–1.11) 0.72 (0.09–1.35) * 0.19 (–0.44–0.81)
Consensus in care and treatment
Among staff (no vs. yes) ref 1.00 (–1.37–3.37) 0.82 (–0.83–2.47) 0.42 (–1.18–2.02) 2.16 (–0.24–4.55) 0.87 (–1.06–2.80) 1.06 (–0.90–3.01)
Among family (no vs. yes) ref –0.63 (–2.48–1.23) –0.57 (–2.30–1.17) –0.08 (–1.99–1.83) 0.75 (–1.75–3.26) –0.52 (–2.47–1.44) n/a
Among all involved (no vs. yes) ref –0.85 (–3.34–1.65) –0.92 (–3.25–1.40) –0.86 (–3.20–1.48) 0.30 (–2.62–3.21) 0.07 (–2.84–2.98) –0.50 (–3.08–2.08)
QoD-LTC: Quality of Dying in Long-Term Care. EOLD-CAD: End of Life in Dementia Scale-Comfort Assessment while Dying. LTCF: long term care facility. CI: confidence interval.
Generalised mixed models with each end of life care outcome as the dependant variables, length of stay as the independent variable, age, gender, marital status, place of admission,
cancer, dementia, physical functioning, LTCF type, LTCF funding status and country as covariates and a variable identifying each LTCF was added as a random factor. p value < 0.05 *,
p value < 0.01 **.
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3.3. Contact with Health Services in the Last Month of Life and Place of Death
Residents with a length of stay of over 5 years had significantly fewer hospital admissions in the
last month of life compared to under 1 month (p = 0.008). No significant associations were identified
between physician visits and length of stay or emergency department visits and length of stay. Death
in hospital was significantly less likely compared to death in a LTCF at a length of stay of 3 to 5 years
(p = 0.044), however no trend was identified as length of stay increased.
3.4. Presence of Advance Directives
Residents were significantly more likely to have a written advance directive in place at 3 to 5 years
and over 5 years, compared to under 1 month post admission (p = 0.002 and p = 0.015, respectively).
Residents were also significantly more likely to have a lasting power of attorney for personal welfare in
place between 1 to 2 years (p = 0.004), 2 to 3 years (p = 0.025), 3 to 5 years (p = 0.024) and over 5 years
(p = 0.001), compared to under 1 month. The likelihood of a staff member having spoken with the
resident about end of life preferences was significantly associated with length of stay over 5 years,
compared to 1 month (p = 0.031). The likelihood of a staff member having spoken with a relative about
end of life preferences was significantly associated with length of stay of 3 to 5 years, compared to
under 1 month (p = 0.025).
3.5. Consensus on Care and Treatment in the Last Month of Life
No significant associations were identified between length of stay and consensus on care and
treatment in the last month of life among LTCF staff, among family or among all those involved in the
resident’s care.
4. Discussion
4.1. Summary of Main Findings
Longer lengths of stay were associated with higher scores of quality of care in the last month
of life and on the personhood, closure and preparatory tasks subscales. Longer lengths of stay were
also associated with higher scores of comfort in the last week of life, on all subscales except the dying
symptoms subscale. Associations between longer lengths of stay and quality of end of care occurred
earlier than in comfort in the last week of life, with significantly higher scores identified from 3 months
compared to 1 year.
A slight but statistically significant association was identified with fewer hospital admissions and
resident deaths in hospital when length of stay was longer. In addition, longer stay residents were
more likely to have written advance directives and lasting power of attorney in place, and have had a
staff member discuss end of life care with either themselves or a relative. No significant associations
were identified between length of stay and physician visits, emergency department visits or consensus
on care and treatment. The analysis controlled for resident characteristics associated with variation in
length of stay and country of residence.
4.2. Strengths and Limitations
This is the first study of which the research team is aware that focuses specifically on the
relationship between length of stay in an LTCF and end of life care. A strength of the data used in this
analysis is their representativeness of a large sample of LTCFs across six European countries. As the
study was retrospective, the data were not limited by a follow up period, therefore data on length of
stay is available for residents with especially long lengths of stay (no right censoring).
The main limitation of the study is that the data were collected by staff members up to 3 months
after the resident’s death. Such an approach has a number of implications for the validity of the
data. Firstly, the risk of recall bias increases, however, data collected on length of stay cannot be
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biased as there is no loss to follow up. In addition, if such as bias exists in this dataset as opposed to
non-systematic measurement error, it would be the same across all countries, although the direction of
the bias is unclear [45].
Secondly, the relationship between the staff member providing the data and the resident may
affect the findings. It is possible that staff members who did not feel they knew the resident well
enough to answer the questionnaire, and could not access written records on the residents care, did not
return the questionnaire, leading to a bias in the data towards staff members with closer relationships
with the residents.
Further to this, one explanation for the findings could be that staff members may feel they know
and understand residents with longer lengths of stay more than recently admitted residents, and are
therefore more confident in their judgement of resident experience. As some of the indicators used in
the EOLD-CAD are relatively subjective to judgement (fear, serenity, anxiety etc.) the findings may be
influenced by greater confidence in the staff member to make these assessments, and therefore more
likely to provide appropriate care, i.e., symptom management.
There are also specific limitations to each of the measures used to indicate quality of end of life
care. For example, data were not collected on the time when written advance directives or lasting
power of attorney were established, therefore it is unclear if these occurred prior to LTCF admission.
Discussions with the resident and relative about end of life care may have occurred, however no data
were collected on whether the decisions made in these conversations were recorded or acted upon,
where possible. Data collected on advance directives are specific to the availability and legality of
advance directives in each country. For example, the data from England does not necessarily indicate
that a conversation has occurred between LTCF staff and the resident, it is possible that advanced
care planning documentation collected as part of the Gold Standard Framework was used to obtain
the answer, which were neither initiated or filled in by the residents themselves [46]. Future research
could further contextualise these findings by including the approach to end of life care adopted at each
facility, including staff mix and training.
Finally, the data used in this analysis is limited to consensus in care and treatment as judged only
by one staff member and not family members. The analysis is limited by a lack of data collected from
residents and relatives’ perspectives on their perceptions of the quality of care at end of life.
4.3. Interpretation of Findings
The primary finding of this analysis is that residents who have resided in an LTCF for a longer
length of time had better quality of care and comfort at end of life than recent LTCF admissions, after
controlling for characteristics of short and long stay resident populations.
Differences in the findings for each of the QoD-LTC subscales require further discussion.
The preparatory tasks subscale refers to activities which can be planned in advance (treatment
preferences in writing, establishing a named decision-maker, funeral planning) indicating that lack of
time for such activities to be enacted by LTCF staff may explain lower scores among newly admitted
residents. Similarly, the personhood subscale focuses on the relationship between the resident and
wider staff (a nurse or aide with whom the resident felt comfortable, affectionate touch daily, physician
knew him or her as a whole person) which, again, develop over time.
However, the items on the dying symptoms subscale of the EOLD-CAD (choking, gurgling,
difficulty swallowing, shortness of breath) are arguably more difficult for LTCF staff to modify without
physician involvement. Additionally, data were not collected on whether the resident received treatment
for such symptoms, therefore, in this study the presence of such symptoms does not necessarily indicate
poorer quality of care.
In a review of preconditions for successful advance care planning in nursing homes, five domains
were identified; sufficient knowledge and skills, willingness and ability to participate in advance care
planning, a good relationship (between staff and family caregivers and residents), availability of an
administrative system for documenting wishes and monitoring care and supportive contextual factors
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within the nursing home [47]. Applied to the findings of this paper, a longer length of residence
before death could allow for the involvement of an appropriately skilled professional, for a record
of resident wishes to be written and accessible or for sufficient time and resources to be allocated to
establishing preferences at end of life care. However, as the association only becomes significant after
1 year of residence, a more plausible explanation could be that it takes this long for a relationship to be
established between LTCF staff, residents and their families.
The few significant results identified for consensus in care and contact with health services shows
that these experiences remain consistent regardless of subsequent length of stay. Although the analysis
failed to show a difference across the groups, this could indicate that if consensus is not established in
the first month after admission, it is unlikely to be subsequently achieved. Alternatively, admissions to
either hospital or an emergency department for preventable reasons (pneumonia, urinary tract infections
etc.) are common in this population, however, the likelihood may not differ based on length of stay.
4.4. Implications for Future Research, Policy and Practice
International epidemiological research on the health and health care needs of LTCF residents
is gaining more attention [48–50], allowing for heterogeneity in the care residents’ experience to be
explored further. Despite the emphasis on ageing in place [51], and a common preference for older
adults to remain living in the community until death [52], there is little evidence to suggest that cohorts
on admission are in poorer health or have shorter lengths of stay than those in previous years [53].
Further research is needed to explore the underlying reasons for this trend, and its implications for
providing good quality end of life care to all LTCF residents. The inclusion of LTCF residents in
nationally representative epidemiological studies, allowing for longitudinal analysis of characteristics
prior to admission [54] and better identification of LTCF residents in existing routinely collected
datasets [55], would greatly support research in this area.
Although numerous interventions to improve end of life care have been developed and implemented
in LTCFs, few have tailored their approach to residents depending on length of stay. In a recent scoping
review of implementation strategies for such interventions, prioritising time for staff members to
provide end of life care, and ensuring staff are available for residents to develop a relationship
with, allowing discussions on end of life to occur, were highlighted as facilitators to successful
implementation [56]. An approach which can be tailored to shorter and longer stay residents is needed,
including how such an environment can be developed prior to resident admission. In particular,
further research is needed to explore the experiences of residents with lengths of stay under 1 month
and the underlying mechanisms that account for fewer indicators of end of life care.
5. Conclusions
Older adults residing in LTCFs often have multiple health needs, are likely to be approaching
end of life and require good quality end of life care. This study explored associations between length
of stay in LTCF residents with five measures of end of life care, using data on deceased residents in
six European countries. In addition to the differences in population characteristics of shorter and
longer stay residents, the findings of this analysis indicate that residents with longer lengths of stay
experience better end of life care than those with shorter lengths of stay on some of the indicators
explored. This trend is identified even after controlling for resident characteristics associated with
variation in length of stay and country of residence. Further research is needed to explore why such
an association is found, and how appropriate end of life care can be provided to all residents from
admission to death.
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